Cargando…

Small Molecule Inhibition of an Exopolysaccharide Modification Enzyme is a Viable Strategy To Block Pseudomonas aeruginosa Pel Biofilm Formation

Biosynthesis of the Pel exopolysaccharide in Pseudomonas aeruginosa requires all seven genes of the pelABCDEFG operon. The periplasmic modification enzyme PelA contains a C-terminal deacetylase domain that is necessary for Pel-dependent biofilm formation. Herein, we show that extracellular Pel is no...

Descripción completa

Detalles Bibliográficos
Autores principales: Razvi, Erum, DiFrancesco, Benjamin R., Wasney, Gregory A., Morrison, Zachary A., Tam, John, Auger, Anick, Baker, Perrin, Alnabelseya, Noor, Rich, Jacquelyn D., Sivarajah, Piyanka, Whitfield, Gregory B., Harrison, Joe J., Melnyk, Roman A., Nitz, Mark, Howell, P. Lynne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10269871/
https://www.ncbi.nlm.nih.gov/pubmed/37098898
http://dx.doi.org/10.1128/spectrum.00296-23
_version_ 1785059269446467584
author Razvi, Erum
DiFrancesco, Benjamin R.
Wasney, Gregory A.
Morrison, Zachary A.
Tam, John
Auger, Anick
Baker, Perrin
Alnabelseya, Noor
Rich, Jacquelyn D.
Sivarajah, Piyanka
Whitfield, Gregory B.
Harrison, Joe J.
Melnyk, Roman A.
Nitz, Mark
Howell, P. Lynne
author_facet Razvi, Erum
DiFrancesco, Benjamin R.
Wasney, Gregory A.
Morrison, Zachary A.
Tam, John
Auger, Anick
Baker, Perrin
Alnabelseya, Noor
Rich, Jacquelyn D.
Sivarajah, Piyanka
Whitfield, Gregory B.
Harrison, Joe J.
Melnyk, Roman A.
Nitz, Mark
Howell, P. Lynne
author_sort Razvi, Erum
collection PubMed
description Biosynthesis of the Pel exopolysaccharide in Pseudomonas aeruginosa requires all seven genes of the pelABCDEFG operon. The periplasmic modification enzyme PelA contains a C-terminal deacetylase domain that is necessary for Pel-dependent biofilm formation. Herein, we show that extracellular Pel is not produced by a P. aeruginosa PelA deacetylase mutant. This positions PelA deacetylase activity as an attractive target to prevent Pel-dependent biofilm formation. Using a high-throughput screen (n = 69,360), we identified 56 compounds that potentially inhibit PelA esterase activity, the first enzymatic step in the deacetylase reaction. A secondary biofilm inhibition assay identified methyl 2-(2-pyridinylmethylene) hydrazinecarbodithioate (SK-017154-O) as a specific Pel-dependent biofilm inhibitor. Structure-activity relationship studies identified the thiocarbazate as a necessary functional group and that the pyridyl ring could be replaced with a phenyl substituent (compound 1). Both SK-017154-O and compound 1 inhibit Pel-dependent biofilm formation in Bacillus cereus ATCC 10987, which has a predicted extracellular PelA deacetylase in its pel operon. Michaelis-Menten kinetics determined SK-017154-O to be a noncompetitive inhibitor of PelA, while compound 1 did not directly inhibit PelA esterase activity. Cytotoxicity assays using human lung fibroblast cells showed that compound 1 is less cytotoxic than SK-017154-O. This work provides proof of concept that biofilm exopolysaccharide modification enzymes are important for biofilm formation and can serve as useful antibiofilm targets. IMPORTANCE Present in more than 500 diverse Gram-negative and 900 Gram-positive organisms, the Pel polysaccharide is one of the most phylogenetically widespread biofilm matrix determinants found to date. Partial de-N-acetylation of this α-1,4 linked N-acetylgalactosamine polymer by the carbohydrate modification enzyme PelA is required for Pel-dependent biofilm formation in Pseudomonas aeruginosa and Bacillus cereus. Given this and our observation that extracellular Pel is not produced by a P. aeruginosa PelA deactylase mutant, we developed an enzyme-based high-throughput screen and identified methyl 2-(2-pyridinylmethylene) hydrazinecarbodithioate (SK-017154-O) and its phenyl derivative as specific Pel-dependent biofilm inhibitors. Michaelis-Menten kinetics revealed SK-017154-O is a noncompetitive inhibitor and that its noncytotoxic, phenyl derivative does not directly inhibit P. aeruginosa PelA esterase activity. We provide proof of concept that exopolysaccharide modification enzymes can be targeted with small molecule inhibitors to block Pel-dependent biofilm development in both Gram-negative and Gram-positive bacteria.
format Online
Article
Text
id pubmed-10269871
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher American Society for Microbiology
record_format MEDLINE/PubMed
spelling pubmed-102698712023-06-16 Small Molecule Inhibition of an Exopolysaccharide Modification Enzyme is a Viable Strategy To Block Pseudomonas aeruginosa Pel Biofilm Formation Razvi, Erum DiFrancesco, Benjamin R. Wasney, Gregory A. Morrison, Zachary A. Tam, John Auger, Anick Baker, Perrin Alnabelseya, Noor Rich, Jacquelyn D. Sivarajah, Piyanka Whitfield, Gregory B. Harrison, Joe J. Melnyk, Roman A. Nitz, Mark Howell, P. Lynne Microbiol Spectr Research Article Biosynthesis of the Pel exopolysaccharide in Pseudomonas aeruginosa requires all seven genes of the pelABCDEFG operon. The periplasmic modification enzyme PelA contains a C-terminal deacetylase domain that is necessary for Pel-dependent biofilm formation. Herein, we show that extracellular Pel is not produced by a P. aeruginosa PelA deacetylase mutant. This positions PelA deacetylase activity as an attractive target to prevent Pel-dependent biofilm formation. Using a high-throughput screen (n = 69,360), we identified 56 compounds that potentially inhibit PelA esterase activity, the first enzymatic step in the deacetylase reaction. A secondary biofilm inhibition assay identified methyl 2-(2-pyridinylmethylene) hydrazinecarbodithioate (SK-017154-O) as a specific Pel-dependent biofilm inhibitor. Structure-activity relationship studies identified the thiocarbazate as a necessary functional group and that the pyridyl ring could be replaced with a phenyl substituent (compound 1). Both SK-017154-O and compound 1 inhibit Pel-dependent biofilm formation in Bacillus cereus ATCC 10987, which has a predicted extracellular PelA deacetylase in its pel operon. Michaelis-Menten kinetics determined SK-017154-O to be a noncompetitive inhibitor of PelA, while compound 1 did not directly inhibit PelA esterase activity. Cytotoxicity assays using human lung fibroblast cells showed that compound 1 is less cytotoxic than SK-017154-O. This work provides proof of concept that biofilm exopolysaccharide modification enzymes are important for biofilm formation and can serve as useful antibiofilm targets. IMPORTANCE Present in more than 500 diverse Gram-negative and 900 Gram-positive organisms, the Pel polysaccharide is one of the most phylogenetically widespread biofilm matrix determinants found to date. Partial de-N-acetylation of this α-1,4 linked N-acetylgalactosamine polymer by the carbohydrate modification enzyme PelA is required for Pel-dependent biofilm formation in Pseudomonas aeruginosa and Bacillus cereus. Given this and our observation that extracellular Pel is not produced by a P. aeruginosa PelA deactylase mutant, we developed an enzyme-based high-throughput screen and identified methyl 2-(2-pyridinylmethylene) hydrazinecarbodithioate (SK-017154-O) and its phenyl derivative as specific Pel-dependent biofilm inhibitors. Michaelis-Menten kinetics revealed SK-017154-O is a noncompetitive inhibitor and that its noncytotoxic, phenyl derivative does not directly inhibit P. aeruginosa PelA esterase activity. We provide proof of concept that exopolysaccharide modification enzymes can be targeted with small molecule inhibitors to block Pel-dependent biofilm development in both Gram-negative and Gram-positive bacteria. American Society for Microbiology 2023-04-26 /pmc/articles/PMC10269871/ /pubmed/37098898 http://dx.doi.org/10.1128/spectrum.00296-23 Text en Copyright © 2023 Razvi et al. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Research Article
Razvi, Erum
DiFrancesco, Benjamin R.
Wasney, Gregory A.
Morrison, Zachary A.
Tam, John
Auger, Anick
Baker, Perrin
Alnabelseya, Noor
Rich, Jacquelyn D.
Sivarajah, Piyanka
Whitfield, Gregory B.
Harrison, Joe J.
Melnyk, Roman A.
Nitz, Mark
Howell, P. Lynne
Small Molecule Inhibition of an Exopolysaccharide Modification Enzyme is a Viable Strategy To Block Pseudomonas aeruginosa Pel Biofilm Formation
title Small Molecule Inhibition of an Exopolysaccharide Modification Enzyme is a Viable Strategy To Block Pseudomonas aeruginosa Pel Biofilm Formation
title_full Small Molecule Inhibition of an Exopolysaccharide Modification Enzyme is a Viable Strategy To Block Pseudomonas aeruginosa Pel Biofilm Formation
title_fullStr Small Molecule Inhibition of an Exopolysaccharide Modification Enzyme is a Viable Strategy To Block Pseudomonas aeruginosa Pel Biofilm Formation
title_full_unstemmed Small Molecule Inhibition of an Exopolysaccharide Modification Enzyme is a Viable Strategy To Block Pseudomonas aeruginosa Pel Biofilm Formation
title_short Small Molecule Inhibition of an Exopolysaccharide Modification Enzyme is a Viable Strategy To Block Pseudomonas aeruginosa Pel Biofilm Formation
title_sort small molecule inhibition of an exopolysaccharide modification enzyme is a viable strategy to block pseudomonas aeruginosa pel biofilm formation
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10269871/
https://www.ncbi.nlm.nih.gov/pubmed/37098898
http://dx.doi.org/10.1128/spectrum.00296-23
work_keys_str_mv AT razvierum smallmoleculeinhibitionofanexopolysaccharidemodificationenzymeisaviablestrategytoblockpseudomonasaeruginosapelbiofilmformation
AT difrancescobenjaminr smallmoleculeinhibitionofanexopolysaccharidemodificationenzymeisaviablestrategytoblockpseudomonasaeruginosapelbiofilmformation
AT wasneygregorya smallmoleculeinhibitionofanexopolysaccharidemodificationenzymeisaviablestrategytoblockpseudomonasaeruginosapelbiofilmformation
AT morrisonzacharya smallmoleculeinhibitionofanexopolysaccharidemodificationenzymeisaviablestrategytoblockpseudomonasaeruginosapelbiofilmformation
AT tamjohn smallmoleculeinhibitionofanexopolysaccharidemodificationenzymeisaviablestrategytoblockpseudomonasaeruginosapelbiofilmformation
AT augeranick smallmoleculeinhibitionofanexopolysaccharidemodificationenzymeisaviablestrategytoblockpseudomonasaeruginosapelbiofilmformation
AT bakerperrin smallmoleculeinhibitionofanexopolysaccharidemodificationenzymeisaviablestrategytoblockpseudomonasaeruginosapelbiofilmformation
AT alnabelseyanoor smallmoleculeinhibitionofanexopolysaccharidemodificationenzymeisaviablestrategytoblockpseudomonasaeruginosapelbiofilmformation
AT richjacquelynd smallmoleculeinhibitionofanexopolysaccharidemodificationenzymeisaviablestrategytoblockpseudomonasaeruginosapelbiofilmformation
AT sivarajahpiyanka smallmoleculeinhibitionofanexopolysaccharidemodificationenzymeisaviablestrategytoblockpseudomonasaeruginosapelbiofilmformation
AT whitfieldgregoryb smallmoleculeinhibitionofanexopolysaccharidemodificationenzymeisaviablestrategytoblockpseudomonasaeruginosapelbiofilmformation
AT harrisonjoej smallmoleculeinhibitionofanexopolysaccharidemodificationenzymeisaviablestrategytoblockpseudomonasaeruginosapelbiofilmformation
AT melnykromana smallmoleculeinhibitionofanexopolysaccharidemodificationenzymeisaviablestrategytoblockpseudomonasaeruginosapelbiofilmformation
AT nitzmark smallmoleculeinhibitionofanexopolysaccharidemodificationenzymeisaviablestrategytoblockpseudomonasaeruginosapelbiofilmformation
AT howellplynne smallmoleculeinhibitionofanexopolysaccharidemodificationenzymeisaviablestrategytoblockpseudomonasaeruginosapelbiofilmformation